In silico and in vitro anti-inflammatory study of phenolic compounds isolated from Eucalyptus maculata resin

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Nature Publishing Group

Series Info

Scientific Reports volume 13, Article number: 2093 (2023)

Orcid

Abstract

Plant resins are rich in bioactive compounds with high medicinal values. However, the chemistry and anti-inflammatory activity of the resins produced by trees of the genus Eucalyptus were scarcely investigated. The inflammatory targets cyclooxygenase-1 (COX-1), COX-2, TNF-, NF-B, and NO were significantly inhibited by the methanolic extract of Eucalyptus maculata kino resin (EME) and its CH2Cl2 soluble fraction (MCF). Sakuranetin (C1), (E)-cinnamic acid (C2), kaempferol 7- methyl ether (C3), 7-O-methyl aromadendrin (C4), and 1,6- dicinnamoyl-O-α-D-glucopyranoside (C5) were isolated from MCF. Three compounds (C1, C2, and C4) showed potent in vitro COX-1 inhibition, while C5 inhibited COX-2, TNF-α, NF-κB, and NO significantly. An in-silico study revealed that C5 had the highest binding affinity to the active site in COX-2 with binding energy score (S) of -14.85 kcal/mol, better than celecoxib (COX-2 inhibitor). In conclusion, 1,6-dicinnamoyl-O-α-D-glucopyranoside (C5) could be investigated further in the search for anti-inflammatory agents.

Description

SJR 2024 0.874 Q1 H-Index 347

Citation

Ali, D. E., Rania, Ezzat, S. M., Maged, Meselhy, M. R., & Essam Abdel-Sattar. (2023). In silico and in vitro anti-inflammatory study of phenolic compounds isolated from Eucalyptus maculata resin. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-28221-y ‌

Endorsement

Review

Supplemented By

Referenced By